4.6 Article

Patient colon and rectal operative outcomes when treated with immune checkpoint inhibitors

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups

Matthias Pinter et al.

Summary: Studies on the application of ICBs in HCC patients are growing, but there are still challenges in patient selection. Combination therapy may show better efficacy in some cases, but caution is needed for specific patient populations.
Article Oncology

Colorectal cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Article Oncology

Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease

Hamzah Abu-Sbeih et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

Article Gastroenterology & Hepatology

Readmissions Within 48 Hours of Discharge: Reasons, Risk Factors, and Potential Improvements

Fabian Grass et al.

DISEASES OF THE COLON & RECTUM (2020)

Article Multidisciplinary Sciences

A decade of immune-checkpoint inhibitors in cancer therapy

Caroline Robert

NATURE COMMUNICATIONS (2020)

Review Immunology

Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma

Mohamed A. Abd El Aziz et al.

VACCINES (2020)

Article Medicine, General & Internal

Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer

T. Andre et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Oncology

Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance

Filipe Martins et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2019)

Review Surgery

The Clavien-Dindo Classification of Surgical Complications Five-Year Experience

Pierre A. Clavien et al.

ANNALS OF SURGERY (2009)